Average Co-Inventor Count = 4.78
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. 3-dimensional Pharmaceuticals, Inc. (32 from 77 patents)
2. Ortho-mcneil Pharmaceutical Corp. (3 from 363 patents)
3. Janssen Pharmaceutica Nv (2 from 2,078 patents)
4. Astrazeneca Ab (2 from 1,500 patents)
5. Dimensional Pharmaceuticals, Inc. (2 from 2 patents)
6. University of Pennsylvania (1 from 2,620 patents)
7. Sterling Winthrop Inc. (1 from 206 patents)
8. Sanofi Sa (1 from 44 patents)
9. Corridor Pharmaceuticals, Inc. (1 from 1 patent)
10. Astra Zeneca U.k. Limited (107 patents)
44 patents:
1. 10118936 - Arginase inhibitors and methods of use
2. 9447122 - Arginase inhibitors and methods of use thereof
3. 9394289 - Inhibitors of c-fms kinase
4. 8894970 - Arginase inhibitors and methods of use thereof
5. 8859602 - Inhibitors of c-fms kinase
6. 7402586 - Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
7. 7241789 - Substituted indoles and their use as integrin antagonists
8. 7030110 - Cyclic oxyguanidine pyrazinones as protease inhibitors
9. 7029654 - Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10. 6900231 - Aminopyridyl-substituted phenyl acetamides as protease inhibitors
11. 6872730 - Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
12. 6855722 - Substituted indoles and their use as integrin antagonists
13. 6730783 - Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors
14. 6706765 - Aminoguanidines and alkoxyguanidines as protease inhibitors
15. 6706021 - Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors